Gaush Meditech (HKSE:02407) Beginning Cash Position: HK$357 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02407 Gaush Meditech Ltd HKSE:02407
60 GF Score
Price HK$4.59
GF Value HK$13.74
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gaush Meditech Beginning Cash Position?

Gaush Meditech HKSE:02407 -1.71% 60 Beginning Cash Position is HK$357 Mil as of Dec. 2025. GuruFocus rates HKSE:02407 with a GF Score™ of 60/100 and a GF Value™ of HK$13.74 (Possible Value Trap). The stock has 3 warning signs investors should review.

Gaush Meditech's Beginning Cash Position for the quarter that ended in Dec. 2025 was HK$357 Mil.

Gaush Meditech's quarterly Beginning Cash Position declined from Dec. 2024 (HK$584 Mil) to Jun. 2025 (HK$461 Mil) and declined from Jun. 2025 (HK$461 Mil) to Dec. 2025 (HK$357 Mil).

Gaush Meditech's annual Beginning Cash Position declined from Dec. 2023 (HK$789 Mil) to Dec. 2024 (HK$661 Mil) and declined from Dec. 2024 (HK$661 Mil) to Dec. 2025 (HK$466 Mil).

Gaush Meditech Beginning Cash Position Related Terms

Gaush Meditech Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Gaush Meditech's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gaush Meditech Beginning Cash Position Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 376.51 680.08 789.19 660.56 465.57

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 666.05 583.85 460.66 357.03 0.00
HKSE:02407
60GF Score
Gaush Meditech Ltd HKSE:02407
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gaush Meditech Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of HK$357 Mil mean?
Gaush Meditech (HKSE:02407) has a Beginning Cash Position of HK$357 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Gaush Meditech and its competitors.
Is Gaush Meditech's Beginning Cash Position too high?
Gaush Meditech's current Beginning Cash Position is HK$357 Mil. Overall, Gaush Meditech has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gaush Meditech's Beginning Cash Position compare to ABT and SYK?
Gaush Meditech's Beginning Cash Position of HK$357 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Gaush Meditech and its competitors. Gaush Meditech's current Beginning Cash Position is HK$357 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gaush Meditech stock overvalued right now?
Based on GuruFocus' analysis, Gaush Meditech (HKSE:02407) is currently considered Possible Value Trap. The stock's GF Value™ is HK$13.74, compared to a current price of HK$4.59 — trading 66.6% below its estimated fair value. The current Beginning Cash Position is HK$357 Mil. Gaush Meditech's overall GF Score™ is 60/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Gaush Meditech (HKSE:02407), the current Beginning Cash Position is HK$357 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gaush Meditech (HKSE:02407) Overvalued in 2026?

Based on GuruFocus' analysis, Gaush Meditech stock appears to be undervalued. The current stock price of HK$4.59 is trading 66.6% below its estimated GF Value™ of HK$13.74. GuruFocus considers Gaush Meditech to be Possible Value Trap.

Key valuation signals for HKSE:02407:

  • Beginning Cash Position: HK$357 Mil
  • GF Value™: HK$13.74 vs. price of HK$4.59 (66.6% below fair value)
  • GF Score™: 60/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02407 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gaush Meditech Business Description

Other Exchanges F7Y:Germany
Address No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of manufacture and sale ophthalmic medical devices and provision of technical services. The segments of the company include Proprietary products segment that derives maximum revenue, develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; Technical services segment provides warranty services, maintenance services and other related consumables; and Others segment.
60GF Score

Get the complete analysis for HKSE:02407

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$4.59
Price
HK$13.74
GF Value